Indrayani Biotech Ltd — Important, 26-02-2026: Company Update

The company's board has approved the financial results for the quarter ended December 31, 2025, showing a consolidated net profit of 0.12 Cr. It also approved new credit facilities of Rs. 5 Cr from Indus Finance Limited. Mr. Dhinakaran Rajagopal resigned as CFO, and Mr. Kunisetty Venkateswara Rao, a qualified Chartered Accountant, was appointed as the new CFO. The company is expediting its partly paid-up Rights Issue, with BSE's in-principle approval already secured. Additionally, prior delays in regulatory filings have been addressed, with all associated fines paid.